Sharp SY - Search Results

1

MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.

Gaspar N, Marshall L, Perryman L, Bax DA, Little SE, Viana-Pereira M, Sharp SY, Vassal G, Pearson AD, Reis RM, Hargrave D, Workman P, Jones C. Gaspar N, et al. Among authors: sharp sy. Cancer Res. 2010 Nov 15;70(22):9243-52. doi: 10.1158/0008-5472.CAN-10-1250. Epub 2010 Oct 8. Cancer Res. 2010. PMID: 20935218 Free PMC article.

2

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.

Holford J, Sharp SY, Murrer BA, Abrams M, Kelland LR. Holford J, et al. Among authors: sharp sy. Br J Cancer. 1998;77(3):366-73. doi: 10.1038/bjc.1998.59. Br J Cancer. 1998. PMID: 9472630 Free PMC article.

3

Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.

Sharp SY, Smith V, Hobbs S, Kelland LR. Sharp SY, et al. Br J Cancer. 1998 Jul;78(2):175-80. doi: 10.1038/bjc.1998.461. Br J Cancer. 1998. PMID: 9683290 Free PMC article.

4

Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

Sharp SY, Rogers PM, Kelland LR. Sharp SY, et al. Clin Cancer Res. 1995 Sep;1(9):981-9. Clin Cancer Res. 1995. PMID: 9816070

5

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.

Kelland LR, Sharp SY, Rogers PM, Myers TG, Workman P. Kelland LR, et al. Among authors: sharp sy. J Natl Cancer Inst. 1999 Nov 17;91(22):1940-9. doi: 10.1093/jnci/91.22.1940. J Natl Cancer Inst. 1999. PMID: 10564678

6

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.

Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR. Beale PJ, et al. Among authors: sharp sy. Br J Cancer. 2000 Jan;82(2):436-40. doi: 10.1054/bjoc.1999.0939. Br J Cancer. 2000. PMID: 10646901 Free PMC article.

7

Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.

Holford J, Beale PJ, Boxall FE, Sharp SY, Kelland LR. Holford J, et al. Among authors: sharp sy. Eur J Cancer. 2000 Oct;36(15):1984-90. doi: 10.1016/s0959-8049(00)00192-1. Eur J Cancer. 2000. PMID: 11000581

8

Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo.

Sharp SY, Kelland LR, Valenti MR, Brunton LA, Hobbs S, Workman P. Sharp SY, et al. Mol Pharmacol. 2000 Nov;58(5):1146-55. doi: 10.1124/mol.58.5.1146. Mol Pharmacol. 2000. PMID: 11040064

9

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin.

Sharp SY, O'Neill CF, Rogers P, Boxall FE, Kelland LR. Sharp SY, et al. Eur J Cancer. 2002 Nov;38(17):2309-15. doi: 10.1016/s0959-8049(02)00244-7. Eur J Cancer. 2002. PMID: 12441268

10

The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.

Cheung KM, Matthews TP, James K, Rowlands MG, Boxall KJ, Sharp SY, Maloney A, Roe SM, Prodromou C, Pearl LH, Aherne GW, McDonald E, Workman P. Cheung KM, et al. Among authors: sharp sy. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3338-43. doi: 10.1016/j.bmcl.2005.05.046. Bioorg Med Chem Lett. 2005. PMID: 15955698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters